Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Dare Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Dare Bioscience Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Dare Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Dare Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Dare Bioscience Inc, Medical Devices Deals, 2012 to YTD 2018 10
Dare Bioscience Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Dare Bioscience Inc, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Dare Bioscience to Acquire CatSper Contraceptive Target from Hydra Biosciences 13
Venture Financing 14
Cerulean Pharma Secures USD15 Million from Hercules Technology Growth Capital 14
Cerulean Pharma Raises US$13 Million In Venture Financing 15
Partnerships 16
Dare Bioscience Enters into Development and Option Agreement with Orbis Biosciences 16
Cerulean Pharma Enters into Partnership with Novartis 17
Cerulean Pharma and AstraZeneca Enter into Research Agreement with National Cancer Institute 18
Cerulean Pharma Enters into Research Agreement with GOG Foundation 19
Merger 20
Dare Bioscience to Merge with Pear Tree Pharma 20
Licensing Agreements 21
Dare Bioscience Enters into Licensing Agreement with Juniper Pharma 21
Dare Bioscience to Enter into Licensing Agreement with Strategic Science & Technologies 23
Equity Offering 25
Dare Bioscience to Raise USD4.1 Million in Public Offering of Shares 25
Dare Bioscience to Raise Funds through Public Offering of Shares 26
Dare Bioscience Plans to Raise up to USD10 Million in Public Offering of Shares 27
Dare Bioscience Raises USD20.7 Million in Equity Financing 28
Cerulean Pharma Raises USD1 Million in First Tranche of Private Placement of Shares 29
Cerulean Pharma Raises USD40 Million in Public Offering of Shares 31
Cerulean Pharma Raises USD1 Million in Private Placement of Shares 33
Cerulean Pharma Completes Underwriters Exercise Of Over-Allotment Option Of IPO For US$67 Million 34
Asset Transactions 36
NewLink Genetics Acquires CRLX101 and CRLX301 from Cerulean Pharma 36
Novartis Institutes for BioMedical Research to Acquire Dynamic Tumor Targeting Platform Technology from Cerulean Pharma 37
Acquisition 38
Cerulean Pharma and Dare Bioscience Combine in Reverse Takeover Transaction 38
Dare Bioscience Inc – Key Competitors 39
Dare Bioscience Inc – Key Employees 40
Dare Bioscience Inc – Locations And Subsidiaries 41
Head Office 41
Other Locations & Subsidiaries 41
Recent Developments 42
Corporate Communications 42
Sep 17, 2018: Dare Bioscience names Greg Matz as board director 42
Jun 06, 2018: Dare Bioscience Expands Leadership Team, Appointing David Friend, Ph.D. to Chief Scientific Officer 43
May 08, 2018: Dare Bioscience Expands Leadership Team, Appointing John Fair to Chief Business Officer 44
Apr 11, 2018: Jessica Grossman Joins Dare Bioscience Board of Directors 45
Jul 20, 2017: Daré Bioscience trading on The NASDAQ Capital Market under the symbol “DARE” 46
Appendix 47
Methodology 47
About GlobalData 47
Contact Us 47
Disclaimer 47
Dare Bioscience Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Dare Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Dare Bioscience Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Dare Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Dare Bioscience Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Dare Bioscience Inc, Medical Devices Deals, 2012 to YTD 2018 10
Dare Bioscience Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Dare Bioscience to Acquire CatSper Contraceptive Target from Hydra Biosciences 13
Cerulean Pharma Secures USD15 Million from Hercules Technology Growth Capital 14
Cerulean Pharma Raises US$13 Million In Venture Financing 15
Dare Bioscience Enters into Development and Option Agreement with Orbis Biosciences 16
Cerulean Pharma Enters into Partnership with Novartis 17
Cerulean Pharma and AstraZeneca Enter into Research Agreement with National Cancer Institute 18
Cerulean Pharma Enters into Research Agreement with GOG Foundation 19
Dare Bioscience to Merge with Pear Tree Pharma 20
Dare Bioscience Enters into Licensing Agreement with Juniper Pharma 21
Dare Bioscience to Enter into Licensing Agreement with Strategic Science & Technologies 23
Dare Bioscience to Raise USD4.1 Million in Public Offering of Shares 25
Dare Bioscience to Raise Funds through Public Offering of Shares 26
Dare Bioscience Plans to Raise up to USD10 Million in Public Offering of Shares 27
Dare Bioscience Raises USD20.7 Million in Equity Financing 28
Cerulean Pharma Raises USD1 Million in First Tranche of Private Placement of Shares 29
Cerulean Pharma Raises USD40 Million in Public Offering of Shares 31
Cerulean Pharma Raises USD1 Million in Private Placement of Shares 33
Cerulean Pharma Completes Underwriters Exercise Of Over-Allotment Option Of IPO For US$67 Million 34
NewLink Genetics Acquires CRLX101 and CRLX301 from Cerulean Pharma 36
Novartis Institutes for BioMedical Research to Acquire Dynamic Tumor Targeting Platform Technology from Cerulean Pharma 37
Cerulean Pharma and Dare Bioscience Combine in Reverse Takeover Transaction 38
Dare Bioscience Inc, Key Competitors 39
Dare Bioscience Inc, Key Employees 40
Dare Bioscience Inc, Subsidiaries 41
List of Figures
Dare Bioscience Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Dare Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Dare Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Dare Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Dare Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Dare Bioscience Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Dare Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Dare Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Dare Bioscience Inc, Medical Devices Deals, 2012 to YTD 2018 10